BOCA RATON, FL., September 4, 2024– PharmaLogic Holdings, Inc. (“PharmaLogic”), the leading independent contract development and manufacturing organization (CDMO) specialized in radiopharmaceuticals, announced Etienne Montagut, President, will participate in a panel discussion as part of this year’s Top of Mind Summit: Life Sciences, held at the Center for Connected Medicine at the University of Pittsburgh Medical Center (UPMC) on Tuesday, September 10.
About PharmaLogic Holdings Corp.
PharmaLogic is the leading independent contract development and manufacturing organization (CDMO) specialized in novel diagnostic and therapeutic radiopharmaceuticals used for the treatment of cancers, neurodegenerative conditions and other diseases. In addition to best-in-class infrastructure in North America, PharmaLogic has decades of expertise in supporting Pharmaceutical Companies with modular manufacturing, end-to-end distribution, and related development services. For more information, visit: www.radiopharmacy.com.